Related Experiment Video
Updated: Sep 3, 2025
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
[Establishment and Preliminary Analysis of Lung Cancer Cell Line A549 with Stable MAP4 K4 Knockdown]
Objective:
To analyze the effect of knocking down MAP4 K4 expression on the proliferation and migration of cancer cells, and to explore its underlining molecular mechanisms.
Methods:
A stable knockdown MAP4 K4 cell line was constructed and the subcellular localization of the cells was determined with immunofluorescence, cell proliferation assay and cell migration assay. In addition, the effects of down-regulated MAP4 K4 expression were analyzed by examining the difference between the proliferation and migration of cancer cells in the knockdown group and those of the control group.
Results:
MAP4 K4 was localized in focal adhesion and cell edges in A549 cells. Stable knockdown of MAP4 K4 expression induced cancer cells to grow in clusters and arrested the progression of the cell cycle and cell migration. Further analysis found that knocking down MAP4 K4 expression in A549 cells induced the accumulation of epithelial cell marker E-cadherin, and subsequently, the down-regulation of N-cadherin, a mesenchymal cell marker, thereby disrupting the "cadherin switch" and the epithelial-mesenchymal conversion. Then, the control group and the knockdown group both received the combined treatment of cisplatin at a final concentration of 5 μmol/L and paclitaxel at a final concentration of 20 nmol/L. The stably knocked down MAP4 K4 expressing cells showed significantly enhanced toxicity of chemotherapeutic drugs to cancer cells.
Conclusion:
The study shows that MAP4 K4 regulates the malignant phenotypes of cancer cells and chemoresistance by regulating "cadherin switch" to promote epithelial-mesenchymal transition in A549 cells.
Insights
Knocking down MAP4K4 expression inhibits cancer cell proliferation and migration by disrupting the epithelial-mesenchymal transition. This also enhances cancer cell sensitivity to chemotherapy drugs like cisplatin and paclitaxel.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The role of MAP4K4 in cancer progression and chemoresistance is not fully understood.
- Understanding MAP4K4's function is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the impact of MAP4K4 knockdown on cancer cell proliferation and migration.
- To elucidate the molecular mechanisms underlying MAP4K4's effects on cancer cells.
- To assess the influence of MAP4K4 on chemoresistance.
Main Methods:
- Stable knockdown of MAP4K4 in A549 cells.
- Immunofluorescence for subcellular localization.
- Cell proliferation and migration assays.
- Analysis of epithelial-mesenchymal transition markers (E-cadherin, N-cadherin).
- Chemotherapy treatment with cisplatin and paclitaxel.
Main Results:
- MAP4K4 knockdown led to cancer cells growing in clusters, cell cycle arrest, and inhibited migration.
- MAP4K4 knockdown induced E-cadherin accumulation and N-cadherin downregulation, disrupting the epithelial-mesenchymal transition.
- MAP4K4 knockdown significantly enhanced the toxicity of cisplatin and paclitaxel to cancer cells.
Conclusions:
- MAP4K4 promotes malignant phenotypes and chemoresistance in A549 cells by regulating the epithelial-mesenchymal transition via the "cadherin switch".
- Targeting MAP4K4 could be a potential strategy to overcome chemoresistance in certain cancers.
